Development of aggressive plasma cell leukaemia under interferon-alpha therapy.
Bladé
J
J
Postgraduate School of Haematology Farreras Valentí, Hospital Clinic i Provincial, University of Barcelona, Spain.
López-Guillermo
A
A
Tassies
D
D
Montserrat
E
E
Rozman
C
C
D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D007952:Leukemia, Plasma Cell / Q000209:etiology*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins